ICICI Prudential Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
IA
ICICI Prudential Asset Management's AZN Position: Q1 2026 in Review
ICICI Prudential Asset Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 4,684 shares — an estimated $861K sold.
ICICI Prudential Asset Management first reported a position in AZN in Q1 2022 and held it in 16 quarters. The position peaked at $861K in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- ICICI Prudential Asset Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
- ICICI Prudential Asset Management sold 4,684 AstraZeneca shares in Q1 2026, an estimated $861K.
- ICICI Prudential Asset Management first reported a position in AstraZeneca in Q1 2022 and held it in 16 quarters.
- ICICI Prudential Asset Management's AstraZeneca position peaked at $861K in Q4 2025.
- 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on ICICI Prudential Asset Management's 13F filing for Q1 2026, filed 11 May 2026.